These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37086183)

  • 41. Permeation enhancer nanovesicles mediated topical delivery of curcumin for the treatment of hyperpigmentation.
    Farooqui RK; Kaurav M; Kumar M; Sudheesh MS; Pandey RS
    J Liposome Res; 2022 Dec; 32(4):332-339. PubMed ID: 35099353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery.
    Patel V; Sharma OP; Mehta T
    Expert Opin Drug Deliv; 2018 Apr; 15(4):351-368. PubMed ID: 29465253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
    Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
    Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.
    Desmet E; Van Gele M; Lambert J
    Expert Opin Drug Deliv; 2017 Jan; 14(1):109-122. PubMed ID: 27348356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of oral tranexamic acid as a novel treatment for melasma with a high benefit-risk ratio.
    Simpson J; Peng L; Ting W
    J Cosmet Dermatol; 2022 Nov; 21(11):6393-6399. PubMed ID: 35972476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical benefit of a multimodal topical approach to treating skin dyspigmentation.
    Draelos ZD; Diaz I
    J Cosmet Dermatol; 2023 Jun; 22(6):1799-1804. PubMed ID: 37102219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation.
    Al-Amin M; Cao J; Naeem M; Banna H; Kim MS; Jung Y; Chung HY; Moon HR; Yoo JW
    Drug Des Devel Ther; 2016; 10():3947-3957. PubMed ID: 27980392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
    Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
    Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
    Botsali A; Esme P; Erbil H; Caliskan E
    Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tranexamic Acid Diminishes Laser-Induced Melanogenesis.
    Kim MS; Bang SH; Kim JH; Shin HJ; Choi JH; Chang SE
    Ann Dermatol; 2015 Jun; 27(3):250-6. PubMed ID: 26082580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
    Austin E; Nguyen JK; Jagdeo J
    J Drugs Dermatol; 2019 Nov; 18(11):. PubMed ID: 31741361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
    Desai S; Chan L; Handog E; Djojoseputro L; Lim J; Ling R; Nguyen H; Tam E; Tang J; Thng S; Tran H
    J Drugs Dermatol; 2023 Apr; 22(4):386-392. PubMed ID: 37026889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of oral tranexamic acid on erythema index in patients with melasma.
    Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
    Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and Best Mode of Delivery for Tranexamic Acid in Post-Inflammatory Hyperpigmentation: A Systematic Review.
    Alsharif SH; Alghamdi AS; Alwayel ZA; Alaklabi SN; Alyamani NA; Sabsabee MA; Bu Izran DAA; Alajlan AM
    Clin Cosmet Investig Dermatol; 2022; 15():2873-2882. PubMed ID: 36597522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposomes in cosmeceutics.
    Rahimpour Y; Hamishehkar H
    Expert Opin Drug Deliv; 2012 Apr; 9(4):443-55. PubMed ID: 22413847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.